Patents by Inventor Yusuke Moritoh

Yusuke Moritoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260306441
    Abstract: A medicament containing an enteropeptidase inhibitor as an active ingredient, for preventing and/or treating polycystic kidney disease; a method for preventing and/or treating polycystic kidney disease, containing administering an effective amount of an enteropeptidase inhibitor to a subject requiring the administration are provided as some embodiments of the present invention. They are highly effective in suppressing and/or improving cyst formation, or suppressing and/or improving kidney volume increase.
    Type: Application
    Filed: April 2, 2026
    Publication date: October 8, 2026
    Applicants: SCOHIA PHARMA, INC., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Jun SUGAMA, Yusuke MORITOH, Masanori WATANABE, Fumihiko HATTANDA, Takuro KAWAMURA, Saori NISHIO
  • Publication number: 20260232648
    Abstract: As specific embodiments of the invention, the present specification discloses a growth hormone secretion promoter containing a somatostatin receptor subtype 5 (“SSTR5”) antagonist as an active ingredient, and the like.
    Type: Application
    Filed: March 26, 2024
    Publication date: August 13, 2026
    Applicant: SCOHIA PHARMA, INC.
    Inventors: JUN SUGAMA, Hideki HIROSE, Yusuke MORITOH, Masanori WATANABE
  • Publication number: 20090042863
    Abstract: The present invention relates to an agent for pancreas protection which contains a combination of a blood glucose lowering drug that does not stimulate insulin secretion and a compound represented by the formula (I) wherein each symbol is defined as in the description, or a salt thereof, or a compound represented by the formula (II) wherein each symbol is defined as in the description, or a salt thereof.
    Type: Application
    Filed: December 27, 2006
    Publication date: February 12, 2009
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Koji Takeuchi, Yusuke Moritoh
  • Publication number: 20070259927
    Abstract: The present invention provides an agent for increasing the pancreatic insulin content useful for the treatment of diabetes and the like. In one embodiment, the present invention provides an agent for increasing the pancreatic insulin content, which contains a blood glucose lowering drug that does not stimulate insulin secretion, and a dipeptidyl-peptidase IV inhibitor in combination.
    Type: Application
    Filed: August 25, 2005
    Publication date: November 8, 2007
    Inventors: Nobuhiro Suzuki, Yusuke Moritoh, Masanori Watanabe